| pubmed-article:17489975 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:17489975 | lifeskim:mentions | umls-concept:C0242629 | lld:lifeskim |
| pubmed-article:17489975 | lifeskim:mentions | umls-concept:C0011306 | lld:lifeskim |
| pubmed-article:17489975 | lifeskim:mentions | umls-concept:C0027540 | lld:lifeskim |
| pubmed-article:17489975 | lifeskim:mentions | umls-concept:C0007613 | lld:lifeskim |
| pubmed-article:17489975 | lifeskim:mentions | umls-concept:C1332714 | lld:lifeskim |
| pubmed-article:17489975 | lifeskim:mentions | umls-concept:C0666743 | lld:lifeskim |
| pubmed-article:17489975 | lifeskim:mentions | umls-concept:C1879547 | lld:lifeskim |
| pubmed-article:17489975 | lifeskim:mentions | umls-concept:C0598622 | lld:lifeskim |
| pubmed-article:17489975 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:17489975 | pubmed:dateCreated | 2007-7-25 | lld:pubmed |
| pubmed-article:17489975 | pubmed:abstractText | Psoriasis is a chronic inflammatory skin disease characterized by hyperproliferation and altered differentiation of keratinocytes in reply to cytokines such as interferon (IFN)-gamma and tumour necrosis factor (TNF)-alpha, provided by infiltrating CD4+ and CD8+ T cells and natural killer cells. Infliximab is a chimeric monoclonal antibody that neutralizes both soluble and membrane-bound TNF-alpha, and that may give a long-term disease remission. | lld:pubmed |
| pubmed-article:17489975 | pubmed:language | eng | lld:pubmed |
| pubmed-article:17489975 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17489975 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:17489975 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17489975 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17489975 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17489975 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17489975 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17489975 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:17489975 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:17489975 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:17489975 | pubmed:issn | 0007-0963 | lld:pubmed |
| pubmed-article:17489975 | pubmed:author | pubmed-author:BediniCC | lld:pubmed |
| pubmed-article:17489975 | pubmed:author | pubmed-author:GirolomoniGG | lld:pubmed |
| pubmed-article:17489975 | pubmed:author | pubmed-author:CavaniAA | lld:pubmed |
| pubmed-article:17489975 | pubmed:author | pubmed-author:NasorriFF | lld:pubmed |
| pubmed-article:17489975 | pubmed:author | pubmed-author:PitàO deO | lld:pubmed |
| pubmed-article:17489975 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:17489975 | pubmed:volume | 157 | lld:pubmed |
| pubmed-article:17489975 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:17489975 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:17489975 | pubmed:pagination | 249-58 | lld:pubmed |
| pubmed-article:17489975 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:17489975 | pubmed:meshHeading | pubmed-meshheading:17489975... | lld:pubmed |
| pubmed-article:17489975 | pubmed:meshHeading | pubmed-meshheading:17489975... | lld:pubmed |
| pubmed-article:17489975 | pubmed:meshHeading | pubmed-meshheading:17489975... | lld:pubmed |
| pubmed-article:17489975 | pubmed:meshHeading | pubmed-meshheading:17489975... | lld:pubmed |
| pubmed-article:17489975 | pubmed:meshHeading | pubmed-meshheading:17489975... | lld:pubmed |
| pubmed-article:17489975 | pubmed:meshHeading | pubmed-meshheading:17489975... | lld:pubmed |
| pubmed-article:17489975 | pubmed:meshHeading | pubmed-meshheading:17489975... | lld:pubmed |
| pubmed-article:17489975 | pubmed:meshHeading | pubmed-meshheading:17489975... | lld:pubmed |
| pubmed-article:17489975 | pubmed:meshHeading | pubmed-meshheading:17489975... | lld:pubmed |
| pubmed-article:17489975 | pubmed:meshHeading | pubmed-meshheading:17489975... | lld:pubmed |
| pubmed-article:17489975 | pubmed:meshHeading | pubmed-meshheading:17489975... | lld:pubmed |
| pubmed-article:17489975 | pubmed:meshHeading | pubmed-meshheading:17489975... | lld:pubmed |
| pubmed-article:17489975 | pubmed:meshHeading | pubmed-meshheading:17489975... | lld:pubmed |
| pubmed-article:17489975 | pubmed:meshHeading | pubmed-meshheading:17489975... | lld:pubmed |
| pubmed-article:17489975 | pubmed:meshHeading | pubmed-meshheading:17489975... | lld:pubmed |
| pubmed-article:17489975 | pubmed:meshHeading | pubmed-meshheading:17489975... | lld:pubmed |
| pubmed-article:17489975 | pubmed:meshHeading | pubmed-meshheading:17489975... | lld:pubmed |
| pubmed-article:17489975 | pubmed:meshHeading | pubmed-meshheading:17489975... | lld:pubmed |
| pubmed-article:17489975 | pubmed:year | 2007 | lld:pubmed |
| pubmed-article:17489975 | pubmed:articleTitle | Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function. | lld:pubmed |
| pubmed-article:17489975 | pubmed:affiliation | Laboratory of Immunology and Allergology, Istituto Dermopatico dell'Immacolata, IRCCS, via dei Monti di Creta 104, 00167 Rome, Italy. | lld:pubmed |
| pubmed-article:17489975 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:17489975 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17489975 | lld:pubmed |
